Nature Biomedical Engineering · 2019 · 561 citations · 37 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyImmune Checkpoint InhibitorsImmune CheckpointsT Cell BiologyT Cell Responses To TumorsPd-l1 BlockadeProgrammed Cell Death Protein 1 (Pd-1) PathwayProgrammed Death-ligand 1 InhibitionT-cell Immune ResponsesT-cell Responses To Tumor Antigens
37
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
Gang Chen, Alexander C. Huang, Wei Zhang et al. · Nature · 2018 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +14
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz, Jonathan J. Havel, Vladimir Makarov et al. · Cell · 2017 · 2.6K citations · Full text
Medicine, Immunology, Oncology +12
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
Ángel García-Díaz, Daniel Sanghoon Shin, Blanca Homet Moreno et al. · Cell Reports · 2017 · 1.9K citations · Full text
Life Sciences, Immunology, Oncology +17
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey, Ling Tong, Yulin Li et al. · Science · 2016 · 1.4K citations · Full text
Medicine, Cancer Biology, Oncology +17